文献速递流行病学与生物统计医学教育与科研方法

母婴临床试验中患者与公众参与(PPI)报告情况的探索性综述

Patient and public involvement (PPI) reporting in maternal and neonatal clinical trials: an exploratory review.
PubMed 文献 · Trials · 2026-03-06

作者建议期刊制定PPI报告指南以促进信息透明。

要点

  • 母婴临床试验中PPI报告率仅14%,信息深度差异大。
  • PPI报告未随时间呈持续增加趋势。
  • 期刊报告指南可能有助于提升PPI信息透明度。

核心结论

  • 母婴临床试验中PPI报告极少,且信息深度差异大,建议期刊出台报告指南以提升透明度。

主要发现

  • 48项试验(14%)报告了PPI,其中40项见于主报告,8项仅见于方案。
  • 48项中20项(42%)在英国开展。
  • 纳入时间段内PPI报告未见持续增加。

临床怎么用

  • 研究者应在试验报告中系统报告PPI活动,可参考期刊指南提升透明度。

局限性

  • 本综述未注册。
  • 仅纳入九种期刊,可能限制代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient and public involvement (PPI) is increasingly a research priority encouraged by health research funders. It is difficult to know, however, how prevalent PPI is within research. The aim of this review was to gain a contemporary understanding of the frequency and types of PPI being reported in maternal and neonatal clinical trial reports, and if an increase in PPI reporting was evident over time. METHODS: An exploratory review of maternal and neonatal trial reports published in nine healthcare journals between 2017 and 2022 was undertaken. A search was conducted for eligible trial reports in each journal using SCOPUS, in addition to a manual search of each journal's archive. Once an eligible trial report was identified, a search was conducted for the trial's associated protocol. Both trial documents were reviewed for any information on PPI activity. Descriptive statistics of the included trials' characteristics were produced. RESULTS: Three hundred and fifty-two trial reports, along with the associated trial protocols for 170 trial reports, were identified and included in the analysis. Of these, 48 trials (14%) reported PPI, either within the main trial record (n = 40) or solely in the trial protocol (n = 8). Twenty (42%) of these trials were conducted in the UK. Thirty-six trials reported PPI contributors in trial design and planning, 29 trials reported PPI during the running of the trial, and 20 trials involved contributors in trial analysis and dissemination. There was no sustained increase in PPI reporting over the included timeframe. CONCLUSIONS: There is minimal reporting of PPI in maternal and neonatal clinical trials, with wide variations in the depth of information provided. PPI reporting guidelines in academic journals may be beneficial in prompting researchers to provide PPI information and to raise awareness of the profile of PPI in maternal and neonatal trial research. REGISTRATION NUMBER: The review was not registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hannon K, Daly D, Smith V, et al. Patient and public involvement (PPI) reporting in maternal and neonatal clinical trials: an exploratory review. Trials. 2026. PMID: 41792805. doi:10.1186/s13063-026-09580-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。